Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Lowe

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Journal of Clinical Immunology|October 2, 2021
Bowel Histology of CVID Patients Reveals Distinct Patterns of Mucosal InflammationCornelia M van Schewick, David M Lowe, Siobhan O Burns, et al.
Journal of Clinical Immunology|June 8, 2019
Chronic Granulomatous Disorder-Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin LevelDavid M Lowe, Philip J Smith, Fernando Moreira, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2017
Respiratory Infections and Antibiotic Usage in Common Variable ImmunodeficiencyJohannes M Sperlich, Bodo Grimbacher, Sarita Workman, et al.
Hepatology Communications|December 15, 2023
Common variable immunodeficiency disorder-related liver disease is common and results in portal hypertension and an increased risk of deathNeil Halliday, Nadia Eden, Henry Somers, et al.
Microbiology Spectrum|October 10, 2023
Erratum for Nunes et al., "Recurrent <i>Campylobacter jejuni</i> Infections with <i>In Vivo</i> Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants"Alexandra Nunes, Mónica Oleastro, Frederico Alves, et al.
Microbiology Spectrum|June 26, 2023
Recurrent Campylobacter jejuni Infections with <i>In Vivo</i> Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance DeterminantsAlexandra Nunes, Mónica Oleastro, Frederico Alves, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2016
Transmission of Hepatitis B Core Antibody and Galactomannan Enzyme Immunoassay Positivity via Immunoglobulin Products: A Comprehensive AnalysisIsobel Ramsay, Rebecca L Gorton, Mauli Patel, et al.
NPJ Digital Medicine|February 15, 2022
Executable network of SARS-CoV-2-host interaction predicts drug combination treatmentsRowan Howell, Matthew A Clarke, Ann-Kathrin Reuschl, et al.
The New England Journal of Medicine|November 29, 2018
Mutagenesis in Norovirus in Response to Favipiravir TreatmentChristopher Ruis, Li-An K Brown, Sunando Roy, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2Shadisadat Esmaeili, Katherine Owens, Joseph F Standing, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Immunology|October 2, 2021
Bowel Histology of CVID Patients Reveals Distinct Patterns of Mucosal InflammationCornelia M van Schewick, David M Lowe, Siobhan O Burns, et al.
Journal of Clinical Immunology|June 8, 2019
Chronic Granulomatous Disorder-Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin LevelDavid M Lowe, Philip J Smith, Fernando Moreira, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 24, 2017
Respiratory Infections and Antibiotic Usage in Common Variable ImmunodeficiencyJohannes M Sperlich, Bodo Grimbacher, Sarita Workman, et al.
Hepatology Communications|December 15, 2023
Common variable immunodeficiency disorder-related liver disease is common and results in portal hypertension and an increased risk of deathNeil Halliday, Nadia Eden, Henry Somers, et al.
Microbiology Spectrum|October 10, 2023
Erratum for Nunes et al., "Recurrent <i>Campylobacter jejuni</i> Infections with <i>In Vivo</i> Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants"Alexandra Nunes, Mónica Oleastro, Frederico Alves, et al.
Microbiology Spectrum|June 26, 2023
Recurrent Campylobacter jejuni Infections with <i>In Vivo</i> Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance DeterminantsAlexandra Nunes, Mónica Oleastro, Frederico Alves, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 15, 2016
Transmission of Hepatitis B Core Antibody and Galactomannan Enzyme Immunoassay Positivity via Immunoglobulin Products: A Comprehensive AnalysisIsobel Ramsay, Rebecca L Gorton, Mauli Patel, et al.
NPJ Digital Medicine|February 15, 2022
Executable network of SARS-CoV-2-host interaction predicts drug combination treatmentsRowan Howell, Matthew A Clarke, Ann-Kathrin Reuschl, et al.
The New England Journal of Medicine|November 29, 2018
Mutagenesis in Norovirus in Response to Favipiravir TreatmentChristopher Ruis, Li-An K Brown, Sunando Roy, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2Shadisadat Esmaeili, Katherine Owens, Joseph F Standing, et al.
Pageof 10